Uncategorized

Licensing agreement with Sensient technologies Elkimia is proud to announce that it has entered into licensing agreement with Sensient Technologies to manufacture and commericialize its first Microsporin Amino mimic derived from Elkimia’s innovative platform.  ” I am happy to see that all the hard work paid off and we look forward to deepening our partnership […]